Vertex Pharmaceuticals (VRTX)

Add to Watchlists Create an Alert
78.29 -0.14  -0.18%   NASDAQ May 23, 4:58PM BATS Real time Currency in USD

Vertex Pharmaceuticals Cash from Investing TTM:

-231.71M for March 31, 2013
View Full Chart

Vertex Pharmaceuticals Cash from Investing TTM Chart

    Vertex Pharmaceuticals Historical Cash from Investing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -231.71M
    Dec. 31, 2012 -425.82M
    Sept. 30, 2012 -820.75M
    June 30, 2012 -668.08M
    March 31, 2012 -425.24M
    Dec. 31, 2011 212.41M
    Sept. 30, 2011 430.49M
    June 30, 2011 406.63M
    March 31, 2011 274.49M
    Dec. 31, 2010 7.301M
    Sept. 30, 2010 -370.78M
    June 30, 2010 -325.84M
    March 31, 2010 -450.15M
    Dec. 31, 2009 -508.73M
    Sept. 30, 2009 -31.47M
    June 30, 2009 -177.85M
    March 31, 2009 -129.07M
    Dec. 31, 2008 -360.65M
    Sept. 30, 2008 -146.40M
    June 30, 2008 138.72M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Investing (TTM)

    Definition: Cash from Investing

    Learn More

    Get data for

    VRTX Cash from Investing TTM Benchmarks

    Companies
    Cleveland BioLabs 1.372M
    Gilead Sciences -11.85B
    Merck -6.805B

    VRTX Cash from Investing TTM Rankings

    Overall 47th percentile
    4168 of 8006
    Sector 21st percentile
    537 of 686 in Healthcare
    Industry 18th percentile
    202 of 248 in Biotechnology

    VRTX Cash from Investing TTM Range, Past 5 Years

    Minimum -820.75M Sep 2012
    Maximum 430.49M Sep 2011
    Average -180.12M